A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma

Recruiting now · Not applicable

Conditions studied: Glioma, Tumor, Electrocorticography, Brain

In brief

The goal of this clinical trial is to collect data on the use of the CIPHER System when used by a surgeon during brain tumor removal. The main questions it aims to answer are: * To evaluate the safety of the CIPHER System when used during brain tumor surgery (Primary) * To evaluate the function of the electrodes under recording and stimulating conditions during surgery (Secondary) Participants will undergo standard-of-care surgery to remove their tumor. Just before the tumor is removed, the CIPHER System will be tested on the main tumor and the surrounding margin areas. Participants will be monitored during standard hospital visits occurring during the recovery period after surgery as well as two- and six-weeks after surgery.

Key facts

Study ID
NCT07465796
Run by
Coherence Neuro Australia Pty Limited
People needed
10
Starts
2026-05-22
Expected to finish
2026-09-01
Last updated by the study team
2026-06-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.